论文部分内容阅读
背景:在降低稳定性冠心病患者的心血管事件发生风险方面,予经皮冠状动脉介入(PCI)联合强化药物治疗及生活方式干预(最佳内科治疗)的初期治疗策略是否优于单一最佳内科治疗,目前尚不确定。方法:进行一
BACKGROUND: Whether the initial treatment strategy for percutaneous coronary intervention (PCI) in combination with intensive medical therapy and lifestyle intervention (best medical therapy) is superior to single best in reducing the risk of cardiovascular events in patients with stable coronary artery disease Medical treatment, is not yet confirmed. Method: Conduct one